Messaging features enable patients to contact providers between appointments
A Multicentre, Randomised, Double-Blind, Placebo Controlled, Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of Afamelanotide (CUV1647) for the Prophylactic Treatment of Pre-Cancerous Skin Lesions of the Head, Forearms and Hands in Immune Compromised, Organ Transplant Patients (Report)
But as these drugs have surged in popularity, so has a new DIY trend: microdosing
Watch-out: Founder, CEO, and founding year not publicly disclosed (no LinkedIn, Crunchbase, or press)
Even minor details, such as the type of container used to keep the ingredients fresh and active, must be considered